Joseph Keegan, Winnie Wan, Kevin King, Peter DeComo, John Kuzmishin, John Miclot, Elizabeth Woo, and Edward Machuga | GenomeWeb
Joseph Keegan has been named president and CEO of ForteBio, effective Sept. 24. Keegan joins the firm from Molecular Devices, where he served as president and CEO until the firm was acquired earlier this year by MDS. Keegan replaces founding CEO Winnie Wan, who will continue to serve on ForteBio’s board of directors.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.